Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy

Cancer cells predominantly adapt the frequent but less efficient glycolytic process to produce ATPs rather than the highly efficient oxidative phosphorylation pathway. Such a regulated metabolic pattern in cancer cells offers promising therapeutic opportunities to kill tumors by glucose depletion or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Penghao, An, Bolin, Jie, Zhongming, Wang, Liping, Qiu, Shuwen, Ge, Changhao, Wu, Qihui, Shi, Jianlin, Huo, Minfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Living Materials edited by Chao Zhong
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792908/
https://www.ncbi.nlm.nih.gov/pubmed/36582449
http://dx.doi.org/10.1016/j.mtbio.2022.100515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792908/
https://www.ncbi.nlm.nih.gov/pubmed/36582449
http://dx.doi.org/10.1016/j.mtbio.2022.100515

Ejemplares similares